Louise Kirman

Louise Kirman is a seasoned professional in medicinal chemistry with extensive experience across multiple leading companies in the biotechnology and pharmaceutical sectors. Currently serving as the Senior Director of Medicinal Chemistry at Delphia Therapeutics since June 2023, Louise also held the position of Senior Director of Medicinal Chemistry at Stablix, Inc. earlier in 2023. Prior roles include Director and Associate Director of Medicinal Chemistry at Cedilla Therapeutics from April 2019 to January 2023. Louise’s foundational experience was acquired during nearly 18 years at Novartis Institutes for BioMedical Research, where progression through various roles in Global Discovery Chemistry highlighted a strong career trajectory starting from Research Associate to Investigator. Education includes a BSc (Hons) in Pharmaceutical Chemistry from Sheffield Hallam University, completed in 2001.